MARSHALL WACE, LLP - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 54 filers reported holding PDS BIOTECHNOLOGY CORP in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$347,416
-5.7%
68,795
-6.0%
0.00%0.0%
Q2 2023$368,297
-56.9%
73,220
-47.3%
0.00%
-50.0%
Q1 2023$854,899
+81.8%
139,008
+290.1%
0.00%
+100.0%
Q4 2022$470,342
+473.6%
35,632
+29.1%
0.00%
Q3 2022$82,000
-70.8%
27,598
-64.0%
0.00%
-100.0%
Q2 2022$281,000
-73.4%
76,745
-55.0%
0.00%
-50.0%
Q1 2022$1,056,000
+89.6%
170,479
+147.3%
0.00%
+100.0%
Q4 2021$557,000
-35.8%
68,929
+18.5%
0.00%
-75.0%
Q3 2021$867,000
+331.3%
58,173
+31.5%
0.00%
+300.0%
Q1 2021$201,00044,2320.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q2 2022
NameSharesValueWeighting ↓
INSPIRION WEALTH ADVISORS, LLC 330,874$1,670,9140.33%
TANG CAPITAL MANAGEMENT LLC 400,000$2,020,0000.28%
AMUSSEN HUNSAKER ASSOCIATES LLC 75,016$377,3300.08%
Nebula Research & Development LLC 25,708$129,8250.07%
Corton Capital Inc. 22,091$111,5600.06%
Sofinnova Investments, Inc. 142,635$720,3070.04%
LAZARI CAPITAL MANAGEMENT, INC. 11,000$55,5500.03%
OCCUDO QUANTITATIVE STRATEGIES LP 24,369$123,0630.02%
WINTON GROUP Ltd 21,256$107,3430.01%
Truvestments Capital LLC 1,372$6,9290.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders